Laurus Labs Q2 PAT seen up 7.3% YoY to Rs. 54.5 cr: Kotak
Net Sales are expected to increase by 3.9 percent Y-o-Y (up 11.1 percent Q-o-Q) to Rs. 545.8 crore, according to Kotak.
Kotak has come out with its second quarter (July-September) earnings estimates for the Pharmaceuticals sector. The brokerage house expects Laurus Labs to report net profit at Rs. 54.5 crore up 7.3% year-on-year (up 40.2% quarter-on-quarter).
Net Sales are expected to increase by 3.9 percent Y-o-Y (up 11.1 percent Q-o-Q) to Rs. 545.8 crore, according to Kotak.
Earnings before interest, tax, depreciation and amortization (EBITDA) are likely to rise by 5.3 percent Y-o-Y (up 20.4 percent Q-o-Q) to Rs. 116.2 crore.
Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Read More
Play in Progress 
